Filing Details

Accession Number:
0001209191-20-041793
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-08 17:39:13
Reporting Period:
2020-07-07
Accepted Time:
2020-07-08 17:39:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1481646 Accolade Inc. ACCD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453957 N Robert Cavanaugh C/o Accolade, Inc.
1201 Third Avenue, Suite 1700
Seattle WA 98101
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-07 87,360 $0.00 125,498 No 4 C Direct
Common Stock Acquisiton 2020-07-07 10,160 $0.00 135,658 No 4 X Direct
Common Stock Disposition 2020-07-07 1 $22.00 135,657 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series E Preferred Stock Disposition 2020-07-07 41,907 $0.00 87,360 $0.00
Common Stock Warrant (Right to Buy) Disposition 2020-07-07 10,160 $0.00 10,160 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 2028-03-16 No 4 X Direct
Footnotes
  1. The Series E Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:2.084634091 basis immediately upon closing of the Issuer's initial public offering and had no expiration date.
  2. Upon closing of the Issuer's initial public offering, the Reporting Person exercised a warrant to purchase 10,160 shares of the Issuer's Common Stock at an exercise price per share of $0.0005. The Reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding 1 share subject to the warrant in order to pay the exercise price and issuing to the Reporting Person the remaining 10,159 shares of Common Stock.
  3. The shares subject to this warrant were fully vested prior to exercise.